Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction

Table 3 Multivariable adjusted hazard ratio for each study outcome by gout status

	Hazard Ratio (95% Confidence Interval)
	All study participants
Gout status	No gout	Treated gout	Untreated gout
	N = 3,987	N = 129	N = 89
Mean sUA (SD)	6.06 (1.33)	7.18 (1.80)	7.00 (1.66)
All-cause death	1.00	0.84 (0.47, 1.50)	1.73^a (1.03, 2.91)
CHD mortality	1.00	0.82 (0.43, 1.54)	2.00^b (1.18, 3.36)
Coronary incidence	1.00	0.86 (0.58, 1.34)	1.67^a (1.07, 2.62)
Stroke	1.00	2.11 (0.74, 6.03)	0.83 (0.11, 6.04)

^aP < 0.05 for comparison of untreated gout group to no gout group; ^bP < 0.01 for comparison of untreated gout group to no-gout group. The covariates adjusted for in this regression included: age, gender, blood pressure/hypertension, smoking, diabetes status, physical activity measure, hyperlipidemia, hypertriglyceridemia, renal function, and other non-steroidal anti-inflammatory drug use. Gout medications accounted for in this study were allopurinol, probenecid, and colchicine. CHD, coronary heart disease; sUA, serum urate.

ISSN: 1478-6362